Acro Biomedical (ACBM) Assets Average (2016 - 2025)

Acro Biomedical's Assets Average history runs 10 years deep, the most recent figure standing at $9210.5 for Q4 2025.

• In Q4 2025, Assets Average fell 73.93% year-over-year to $9210.5; the TTM figure through Dec 2025 stood at $9210.5 (down 73.93% YoY), while the FY2025 annual figure was $23036.0, down 49.05% from the prior year.
• Assets Average was $9210.5 for Q4 2025 at Acro Biomedical, down from $28800.0 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $968463.5 in Q1 2021 to a low of $9210.5 in Q4 2025.
• Historically, Assets Average has averaged $389417.4 across 5 years, with a median of $438565.0 in 2023.
• The sharpest annual moves came in 2021 and 2023: Assets Average decreased 0.75% in 2021, then plunged 94.18% in 2023.
• A 5-year view of Assets Average shows it stood at $695452.5 in 2021, then slipped by 4.3% to $665567.0 in 2022, then slumped by 94.18% to $38743.0 in 2023, then declined by 8.82% to $35325.0 in 2024, then tumbled by 73.93% to $9210.5 in 2025.
• The last three Assets Average figures came in at $9210.5 (Q4 2025), $28800.0 (Q3 2025), and $39226.0 (Q2 2025), per Business Quant data.